Potential Med Errors Prompt FDA Action on Vinca Alkaloid Labeling By Diana Ernst, RPh Publish Date January 19, 2021
Injectable NSAID Recalled Due to Particulate Matter Found in Vials By Brian Park, PharmD Publish Date January 11, 2021
FDA: SARS-CoV-2 Mutations May Impact Molecular Tests By Brian Park, PharmD Publish Date January 8, 2021
False Results Possible With Curative SARS-CoV-2 Test, Says FDA By Brian Park, PharmD Publish Date January 5, 2021
FDA Strengthens REMS for Transmucosal Immediate-Release Fentanyl Products By Brian Park, PharmD Publish Date December 28, 2020
Counterfeit HIV Drug Identified in Three US Pharmacies By Diana Ernst, RPh Publish Date December 28, 2020
No Significant Difference Between Sitagliptin, Placebo in Pediatric T2D Trials By Diana Ernst, RPh Publish Date December 7, 2020
FDA: Risk of Inadvertent Intrathecal Administration of Tranexamic Acid Injection By Brian Park, PharmD Publish Date December 4, 2020
Recall: Lidocaine Identified in Dexmedetomidine Vials By Diana Ernst, RPh Publish Date November 20, 2020
Possible Microbial Contamination Prompts Recall of Oral Rinse By Brian Park, PharmD Publish Date October 29, 2020
FDA: NSAID Use Should Be Avoided in Pregnancy Even Sooner Than 30 Weeks By Brian Park, PharmD Publish Date October 16, 2020
Insulin Pens Should Be Dispensed in Original Packaging, Says FDA By Diana Ernst, RPh Publish Date October 16, 2020
FDA: Diphenhydramine Overdoses Linked to New Social Media Challenge By Brian Park, PharmD Publish Date September 25, 2020
FDA Requires Boxed Warning Update for Benzodiazepines By Brian Park, PharmD Publish Date September 24, 2020
Thyroid Medication Recalled Due to Subpotent Tablets By Brian Park, PharmD Publish Date September 21, 2020
FDA Cracks Down on Websites Illegally Selling Opioids By Brian Park, PharmD Publish Date September 11, 2020
FDA: Efficacy, Safety Concerns With Breast Cancer Combo Therapy By Brian Park, PharmD Publish Date September 10, 2020
FDA: Stimulation Trial Should Be Performed Before Implanting SCS for Pain By Brian Park, PharmD Publish Date September 4, 2020
Label Mix-Up Prompts Recall of IV Amiodarone, Tranexamic Acid By Brian Park, PharmD Publish Date September 1, 2020
FDA: Tuberculosis Drugs May Contain Nitrosamine Impurities By Diana Ernst, RPh Publish Date August 27, 2020
FDA: Small Risk of Skin Cancer With Hydrochlorothiazide Use By Brian Park, PharmD Publish Date August 24, 2020
FDA Warns of Risks Associated With Intraocular Use of Moxifloxacin By Brian Park, PharmD Publish Date August 13, 2020
Fresenius Kabi Recalls Dexmedetomidine Over Possible Lidocaine Cross-Contamination By Brian Park, PharmD Publish Date July 23, 2020
FDA: Several Companies Recall Metformin ER Over NDMA Concerns By Brian Park, PharmD Publish Date July 14, 2020
FDA: Risk of Methanol Toxicity With Certain Hand Sanitizers By Diana Ernst, RPh Publish Date July 6, 2020
Supplements With Undeclared Active Ingredients Pose Substantial Health Risk By Cassandra Pardini, PharmD Publish Date June 25, 2020
OTC Cough/Cold Meds Recalled Due to Incorrect Dosing Cups By Brian Park, PharmD Publish Date June 23, 2020
FDA Revokes EUA for COVID-19 Antibody Test, Cracks Down on Fraudulent At-Home Tests By Diana Ernst, RPh Publish Date June 18, 2020
Warning Letters Issued to Several Companies Selling Unapproved “Homeopathic” Injectables By Diana Ernst, RPh Publish Date June 18, 2020
FDA: Vial Caps of Two Neuromuscular Blocking Agents May Not Have Warning Statement By Brian Park, PharmD Publish Date June 4, 2020
FDA: Certain Epinephrine Autoinjector Devices May Have Missing Safety Component By Brian Park, PharmD Publish Date June 2, 2020
FDA: Unacceptable NDMA Levels Identified in Certain Metformin ER Products By Diana Ernst, RPh Publish Date May 29, 2020
Superpotent Lots of Hypothyroidism Treatment NP Thyroid Recalled By Brian Park, PharmD Publish Date May 27, 2020
Unapproved Cannabidiol, Curcumin Injectables Marketed for Multiple Disorders Recalled By Brian Park, PharmD Publish Date May 22, 2020
Recall: Undeclared Antihypertensive Found in Compounded Hair Loss Drug By Brian Park, PharmD Publish Date May 14, 2020
Fiber Supplements Recalled Due to Possible Plastic Contamination By Brian Park, PharmD Publish Date April 30, 2020
FDA Issues Safety Alert Regarding Use of Hydroxychloroquine, Chloroquine for COVID-19 By Diana Ernst, RPh Publish Date April 24, 2020
Pain Medication Recalled Due to Presence of Particulate Matter in Vials By Brian Park, PharmD Publish Date April 22, 2020
Amneal’s Nizatidine Oral Solution Recalled Due to NDMA Concerns By Brian Park, PharmD Publish Date April 20, 2020
FDA: All Ranitidine Products Must Be Removed From the Market By Brian Park, PharmD Publish Date April 1, 2020
Phytonadione Injectable Emulsion Ampules Recalled Following Reports of Glass Injuries By Brian Park, PharmD Publish Date March 27, 2020
Certain Blister Packages of Sandimmune, Neoral Not Child Resistant By Diana Ernst, RPh Publish Date March 19, 2020
FDA, FTC Crack Down on Fraudulent COVID-19 “Treatments” By Diana Ernst, RPh Publish Date March 10, 2020
FDA Strengthens Warning About Risk of Neuropsychiatric Events With Montelukast By Diana Ernst, RPh Publish Date March 5, 2020
Phenytoin Oral Suspension Recalled Due to Potential for Inaccurate Dosing By Brian Park, PharmD Publish Date February 24, 2020
FDA: Bacitracin for Injection to Be Withdrawn From Market By Brian Park, PharmD Publish Date February 3, 2020
FDA: Serious Complications Following Clozapine-Induced Constipation By Diana Ernst, RPh Publish Date January 29, 2020
FDA: Possible Cybersecurity Issues With Certain Patient Monitoring Devices By Steve Duffy Publish Date January 27, 2020
Lamotrigine Recalled Due to Cross-Contamination With Hypertension Med By Brian Park, PharmD Publish Date January 13, 2020
Recall: NDMA Identified in Mylan’s Nizatidine Capsules By Diana Ernst, RPh Publish Date January 8, 2020
FDA: Cases of Respiratory Depression With Gabapentinoids Reported By Diana Ernst, RPh Publish Date December 19, 2019
FDA: Do Not Use Products Distributed by Basic Reset, Biogenyx By Steve Duffy Publish Date December 11, 2019
FDA: Dollar Tree Stores May Be Selling Potentially Harmful OTC Products By Brian Park, PharmD Publish Date November 15, 2019
FDA: Biotin Interference Still Concerning, Particularly With Troponin Tests By Diana Ernst, RPh Publish Date November 6, 2019
FDA: Testing Reveals Unacceptable Levels of NDMA in Two H2 Blockers By Brian Park, PharmD Publish Date November 4, 2019
Potential Presence of Foreign Substance Prompts Recall of Anti-Anxiety Med By Brian Park, PharmD Publish Date October 28, 2019
Recall: Small Amounts of Asbestos Identified in Baby Powder By Brian Park, PharmD Publish Date October 18, 2019
CVS Suspends Sale of Zantac, OTC Generic as More Ranitidine Recalls Announced By Brian Park, PharmD Publish Date October 1, 2019
Maker Halts Distribution of Generic Zantac Due to Possible Carcinogen Publish Date September 20, 2019
FDA: Nitrosamine Impurity Identified in Commonly Used Acid Suppressant By Diana Ernst, RPh Publish Date September 13, 2019
